Composition of ginseng-astragalus polysaccharides and its preparing method

A technology of ginseng polysaccharide and composition, applied in the field of ginseng polysaccharide composition and its preparation, can solve the problems of increasing the risk of adverse reactions, etc., and achieve the effect of strong immune enhancement, no toxic side effects, and stable quality
CN1813787AInactive Publication Date: 2006-08-09广东仁泰药业有限公司

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
广东仁泰药业有限公司
Publication Date
2006-08-09
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention relates to a shenqi polysaccharide composition. It is formed from polysaccharides which are respectively extracted by utilizing 1-3 portions of pilose asiabell root and 1-3 portions of astragalus root and purified, in which the polysaccharide content whose molecular weight range is 10000-10000 is above 80% of total solid substance content. It can be made into shenqi polysaccharide injection and injection freeze-dried powder, and its quality is stable, and can be controlled. Said invention has strong immunologic enhancement.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention relates to a ginseng polysaccharide composition for enhancing immunity and a preparation method thereof. Background technique:

[0002] Shenqi Fuzheng Injection is a traditional Chinese medicine injection made by extracting active ingredients from Codonopsis pilosula and Radix Astragali. It has the functions of strengthening the body, improving the immune function of the human body, and improving the symptoms of patients. It is often used in clinical adjuvant therapy for tumors. However, due to the complex composition of traditional Chinese medicine injection, Shenqi Fuzheng Injection was developed earlier, and the technical conditions at that time were backward, and there were inevitable problems in the degree of purification and quality control of the drug, which increasingly failed to meet the requirements of modern clinical medication. . Some clinical adverse reactions occur from time to time, for example: one case of severe rash ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More